Wikipedia -WSS

Wikipedia

author：fashion 2025-10-03 00:40:25 - browse：2

Scientists Christina Frey and Paul Negulescu work in a lab at Vertex Pharmaceuticals. -- biotech coverage from STAT — Scientists Christina Frey and Paul Negulescu work in a lab at Vertex Pharmaceuticals in San Diego. Sandy Huffaker for STAT

A pain relief drug developed by Vertex Pharmaceuticals succeeded in late-stage clinical trials, the company announced Tuesday, bringing the biopharma giant a step closer to launching what observers believe could be a potential blockbuster and upending decades of pharma failure in a complicated field.

In a pair of randomized, placebo-controlled Phase 3 trials for patients with pain after a tummy tuck or bunion surgery, the drug showed statistically significant pain reduction compared to placebo, meeting the primary endpoints for these studies and the expectations of market analysts. But the experimental therapy didn’t relieve pain better than a combination of acetaminophen and the opioid hydrocodone, a key secondary endpoint observers had been waiting on. And in the bunionectomy trial, the opioid comparator outperformed VX-548 at soothing pain.

The drug, a small molecule known as VX-548, blocks pain-sensing neurons from signaling the pain without the addictive potential of opioids. It was generally safe, with fewer patients on VX-548 reporting adverse events than those taking the placebo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： The explosion of genetic testing requires a new approach

WSS

Mass General, Mayo Clinic look to monetize custom

A pediatrician calls for Congress to pass the child tax credit deal

Dana Farber says 6 studies to be retracted and 31 corrected

How climate

STAT Summit: GSK CEO on pharma giant's new direction

To bolster infectious disease surveillance, genomics powerhouses team up

hotspot

Wikipedia

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

TikTok, Instagram influencers need more rules for drug ads

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Dana Farber says 6 studies to be retracted and 31 corrected

New air purifier tech could be key to improving indoor air quality

Why health workers in Gaza are injured or die at high rates

Duchenne breakthrough therapy leaves behind pioneering families

FDA warns J&J's Abiomed: We will regulate your software

Virginia high school admissions case could be legal follow

Immunocompromised patients offer clues on chronic Covid

entertainment

UnitedHealth’s board chair also owns a personal investment firm

Will Ozempic

CVS is on a mission to consolidate health care. Will it work?

Senate committee scrutinizes Medicare Advantage brokers

Future doctors need a strong humanities education

Dog Aging Project founders on what lies ahead after losing funding

Wikipedia

focus

explore

explore